Jazz Pharmaceuticals’ management team is committed to operating with integrity and dedication to improve patients’ lives by identifying, developing and commercializing innovative products in focused therapeutic areas. Our team has a proven track record of successfully developing and commercializing therapeutics and patient programs that result in better patient care.

Our management team has broad experience and a deep understanding of the pharmaceutical industry. With proven expertise in product development, regulatory and clinical affairs, compliance, portfolio management, product marketing and sales, manufacturing and strategic transactions, members of the executive management team combine their industry expertise with rich experience working together as a team.

Each member of our executive management team comes from a unique background with diverse interests. This group of talented individuals comes together to drive toward a common goal — serving the needs of the patients.

The executive team below is an alphabetical listing of management for Jazz Pharmaceuticals plc and its U.S. operating companies.

Russell J. Cox
Executive Vice President and Chief Operating Officer
Bruce C. Cozadd
Chairman and Chief Executive Officer
Suzanne Sawochka Hooper
Executive Vice President and General Counsel
Heather McGaughey
Senior Vice President, Human Resources
Iain McGill
Senior Vice President, Jazz Pharmaceuticals Europe and Rest of World
Robert McKague
Senior Vice President and Chief Compliance Officer
Michael P. Miller
Senior Vice President, U.S. Commercial
Karen Smith, M.D., Ph.D.
Global Head of Research and Development and Chief Medical Officer
Paul Treacy
Senior Vice President, Technical Operations
Matthew Young
Executive Vice President and Chief Financial Officer